ZIVO vs. SRZN, APTO, PMCB, EVAX, NKGN, SRNE, AIM, SNTI, IKT, and COEP
Should you be buying ZIVO Bioscience stock or one of its competitors? The main competitors of ZIVO Bioscience include Surrozen (SRZN), Aptose Biosciences (APTO), PharmaCyte Biotech (PMCB), Evaxion Biotech A/S (EVAX), NKGen Biotech (NKGN), Sorrento Therapeutics (SRNE), AIM ImmunoTech (AIM), Senti Biosciences (SNTI), Inhibikase Therapeutics (IKT), and Coeptis Therapeutics (COEP). These companies are all part of the "biological products, except diagnostic" industry.
Surrozen (NASDAQ:SRZN) and ZIVO Bioscience (NASDAQ:ZIVO) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment, community ranking and analyst recommendations.
Surrozen has a beta of 0.74, suggesting that its share price is 26% less volatile than the S&P 500. Comparatively, ZIVO Bioscience has a beta of 0.2, suggesting that its share price is 80% less volatile than the S&P 500.
In the previous week, Surrozen had 1 more articles in the media than ZIVO Bioscience. MarketBeat recorded 1 mentions for Surrozen and 0 mentions for ZIVO Bioscience. Surrozen's average media sentiment score of 0.00 beat ZIVO Bioscience's score of -1.00 indicating that ZIVO Bioscience is being referred to more favorably in the news media.
ZIVO Bioscience has lower revenue, but higher earnings than Surrozen. ZIVO Bioscience is trading at a lower price-to-earnings ratio than Surrozen, indicating that it is currently the more affordable of the two stocks.
Surrozen's return on equity of 0.00% beat ZIVO Bioscience's return on equity.
66.6% of Surrozen shares are held by institutional investors. Comparatively, 12.8% of ZIVO Bioscience shares are held by institutional investors. 35.0% of Surrozen shares are held by company insiders. Comparatively, 13.4% of ZIVO Bioscience shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
ZIVO Bioscience received 96 more outperform votes than Surrozen when rated by MarketBeat users. Likewise, 61.11% of users gave ZIVO Bioscience an outperform vote while only 16.67% of users gave Surrozen an outperform vote.
Summary
Surrozen and ZIVO Bioscience tied by winning 7 of the 14 factors compared between the two stocks.
Get ZIVO Bioscience News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZIVO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ZIVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ZIVO Bioscience Competitors List
Related Companies and Tools
